Institutional investors purchased a net $92.2 thousand shares of SRDX during the quarter ended December 2016 and now own 86.66% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RICE, HALL, JAMES & ASSOCIATES L... Bought 14.2 Thousand shares of SurModics Inc
SIMPLEX TRADING LLC Bought 2.0 Thousand shares of SurModics Inc
VANGUARD INVESTMENTS AUSTRALIA L... Bought 600.00 shares of SurModics Inc